Naveen Pemmaraju, Director of Leukemia-Cancer Network, Executive Director of Cancer Medicine, Director of BPDCN at the Department of Leukemia, and Professor at the Department of Leukemia at MD Anderson Cancer Center, shared a post on LinkedIn:
“An historic gathering. A monumental achievement bringing all of us together recently, as we gathered in Chicago this week for the first ever CAM – Classification Advancement Meeting – pathologists and clinicians from all over the world, experts in our own individual fields.
We came together to debate, discuss, and improve the diagnostic criteria for the most complex, rare, and the most difficult-to-diagnose Hematologic malignancies, which will ultimately be for the betterment of patient care and improve research worldwide in Rare Blood Cancers Rare Disease.
I was honored to be invited to serve as clinical chair for one of the sessions – the BPDCN session and thoroughly enjoyed & appreciated learning and contributing in several others.”
Sanam Loghavi, Associate Professor of Pathology at MD Anderson Cancer Center, Medical Director of ECOG-ACRIN Leukemia Bank and Editor in Chief of Image Bank at the American Society of Hematology, shared a post on X:
“Leaving Chicago w/immense gratitude. Exhilarated, proud, optimistic (exhausted).
CAM was a huge success. Several months of preparation + 3 intense days of heated and passionate discussions to everyone who participated and contributed. Onwards and upwards.”
Other articles about BPDCN on OncoDaily.
